ARTICLE | Clinical News
BioChaperone PDGF-BB: Development halted
September 5, 2016 7:00 AM UTC
Adocia said it will halt development of BioChaperone PDGF-BB to treat diabetic foot ulcers after top-line data from a double-blind, Indian Phase III trial in 252 patients showed that 4 ug/cm 2 BioChap...